(Q40574551)
Statements
1 reference
Cross-resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure (English)
1 reference
Baoqing Guo
1 reference
David J Villeneuve
1 reference
Stacey L Hembruff
1 reference
Angie F Kirwan
1 reference
David E Blais
1 reference
Michel Bonin
1 reference
Amadeo M Parissenti
1 reference
1 May 2004
1 reference
1 reference
85
1 reference
1
1 reference
31-51
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference